Assessment of the MRI and Behavioral Test Results in Focal Cerebral Ischemia Reperfusion Model in Rat after Separate and Combined Use of Mouse-Derived Neural Progenitor Cells, Human-Derived Neural Progenitor Cells and Atorvastatin.

CONCLUSION: Both hNPC and mNPC treatments significantly improved functional outcome, and reduced infarct area rate after stroke. Atorvastatin enhanced the therapeutic potency of NPCs, including neurological improvement. PMID: 29204982 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29204982?dopt=Abstract

Source: Turkish Neurosurgery - November 1, 2017 Category: Neurosurgery Authors: Tahta A, Izgi N, Onder TB, Erdag E, Aras Y, Genc C Tags: Turk Neurosurg Source Type: research